Quell Therapeutics
Cell therapy firm specializing in developing treatments using advanced cellular technology.
6
Funding Rounds
$474.7m
Money raised
Overview
Cell therapy firm specializing in developing treatments using advanced cellular technology.
- Business model: B2B
- Headquarters: London
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Quell Therapeutics has raised a total of $314.7m in funding over 6 rounds.
Key Insights:
- Quell Therapeutics Series B round, November 2021: $156m
- Quell Therapeutics Series A (extension) , February 2021: $35.7m
- Quell Therapeutics February 2021 Series A Funding Round: $40m
- Quell Therapeutics Seed round, December 2020: $3m
- Quell Therapeutics Series A round, May 2019: $35m
- Quell Therapeutics May 2019 Series A Funding Round: $45m
Quell Therapeutics Series B round, November 2021
$156m
Quell Therapeutics Series A (extension) , February 2021
$35.7m
Quell Therapeutics February 2021 Series A Funding Round
$40m
Quell Therapeutics Seed round, December 2020
$3m
Quell Therapeutics Series A round, May 2019
$35m
Quell Therapeutics May 2019 Series A Funding Round
$45m
Industries
Quell Therapeutics is active in the following industries: